Today: 16 May 2026
Linde stock today: LIN ends Friday up at $429 as yields rise; earnings and key levels ahead
3 January 2026
1 min read

Linde stock today: LIN ends Friday up at $429 as yields rise; earnings and key levels ahead

NEW YORK, Jan 3, 2026, 3:53 PM ET — Market closed

  • Linde shares rose 0.6% in the latest U.S. session, closing at $429.11.
  • The stock’s move came as investors started 2026 weighing higher bond yields against the next wave of economic data.
  • Focus now shifts to Linde’s expected early-February earnings update and a late-January board transition.

Linde plc shares rose 0.6% to $429.11 at Friday’s close, after trading between $422.34 and $430.73.

The industrial gases supplier — a major source of oxygen, nitrogen and hydrogen for factories and hospitals — is often treated as a read-through on industrial activity.

That matters now because investors are resetting positions for 2026 with interest rates and growth expectations back in focus, and economically sensitive names are again being used as proxies for the cycle.

U.S. stocks ended mixed on Friday while Treasury yields moved higher, with the S&P 500 up 0.19% and the Dow up 0.66%. “Value is outperforming growth and AI infrastructure is up,” said Jed Ellerbroek, portfolio manager at Argent Capital in St. Louis. Reuters

In industrial gases, Air Products & Chemicals rose 1.4%, while chemical maker Dow Inc jumped about 3.9% in the same session.

For Linde, the latest move kept the stock near the top end of Friday’s range and in step with a broader tilt toward industrial and materials shares.

Investors are also looking past the day-to-day tape to Linde’s next earnings checkpoint and whether demand trends in Europe and other end markets are stabilizing.

In its last quarterly update, Linde forecast fourth-quarter adjusted earnings per share — a profit measure that excludes some one-off items — of $4.10 to $4.20, and flagged softer European volumes.

Before the next session, Wall Street will keep one eye on the calendar: Zacks’ earnings schedule lists Linde’s next report for Feb. 5, with an expected EPS of $4.18.

Any guidance update around that report is likely to put pricing discipline, volume trends and currency translation in the spotlight, given Linde’s global footprint.

Governance is another near-term waypoint. Linde has said CEO Sanjiv Lamba is due to take on the additional role of chairman on Jan. 31, when Stephen F. Angel is set to retire from the board, according to an SEC filing.

On the chart, traders will likely use Friday’s $430–$431 area as the first resistance zone, with the $422 level marking near-term support heading into Monday’s open.

Stock Market Today

  • W. R. Berkley (WRB) Shows 45.9% Undervaluation Despite Recent Price Stability
    May 15, 2026, 7:55 PM EDT. W. R. Berkley (WRB) stock has shown limited movement recently with a 1.2% gain over 7 days and a 4.2% decline year-to-date. Analysts use valuation methods like Excess Returns, which estimates intrinsic value by calculating profits above shareholder required returns. With an intrinsic value estimate of $122.79 against a current price near $66.45, the stock appears 45.9% undervalued. The insurer's steady underwriting profile and capital discipline contrast with sector concerns on insurance pricing and interest rate sensitivity. WRB currently scores 2 out of 6 on valuation metrics, highlighting potential but raising caution.

Latest articles

Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

16 May 2026
HCW Biologics shares jumped 262% to $1.22 Friday after the company posted a $3.47 million first-quarter profit, driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. The company faces a possible Nasdaq delisting and will ask shareholders to approve a reverse stock split on June 15. HCW plans to report early Phase 1 data for its alopecia drug in the first half of 2026.
Chevron stock (CVX) in spotlight after Trump vows billions for Venezuela oil reset
Previous Story

Chevron stock (CVX) in spotlight after Trump vows billions for Venezuela oil reset

Lockheed Martin stock jumps near $500 to start 2026 — what investors are watching next
Next Story

Lockheed Martin stock jumps near $500 to start 2026 — what investors are watching next

Go toTop